Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-01 Purchase | 2026-07-02 3:00 pm | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 240,000 | $0.0431 | $10,344 | 117,777,232 (Indirect Direct) | View |
| 2026-06-22 Purchase | 2026-06-24 8:37 pm | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 255,000 | $0.045 | $11,475 | 117,347,232 (Indirect Direct) | View |
| 2026-06-22 Purchase | 2026-06-22 4:30 pm | Oncotelic Therapeutics Inc. | OTLC | Shah Amit B. CFO | 20,000 | $0.05 | $1,000 | 378,837 (Direct) | View |
| 2026-06-15 Purchase | 2026-06-17 7:34 pm | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 335,759 | $0.04471 | $15,013 | 117,042,473 (Indirect Direct) | View |
| 2025-07-08 Purchase | 2025-07-10 5:15 pm | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 198,737 | $0.005 | $994 | 117,041,210 (Indirect Direct) | View |
| 2025-01-29 Purchase | 2025-01-31 5:08 pm | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 346,844 | $0.028 | $9,712 | 116,842,473 (Indirect Direct) | View |
| 2024-11-22 Purchase | 2024-11-26 11:33 am | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 298,499 | $0.0289 | $8,627 | 116,495,629 (Indirect Direct) | View |
| 2024-08-23 Purchase | 2024-08-27 08:00 am | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 500,000 | $0.02 | $10,000 | 116,197,130 (Indirect Direct) | View |
| 2023-06-28 Purchase | 2023-06-30 09:25 am | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 500,000 | $0.02175 | $10,875 | 115,272,130 (Indirect Direct) | View |
| 2023-06-16 Purchase | 2023-06-20 12:00 pm | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 100,000 | $0.026 | $2,600 | 115,197,130 (Indirect Direct) | View |
| 2023-06-14 Purchase | 2023-06-16 12:00 pm | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 400,000 | $0.0326 | $13,040 | 115,097,130 (Indirect Direct) | View |
| 2023-05-26 Purchase | 2023-05-31 09:39 am | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 126,888 | $0.0341 | $4,327 | 114,697,130 (Indirect Direct) | View |
| 2023-05-02 Purchase | 2023-05-02 5:00 pm | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 100,000 | $0.045 | $4,500 | 114,570,242 (Indirect Direct) | View |
| 2022-12-06 Purchase | 2022-12-07 08:00 am | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 120,000 | $0.05 | $6,000 | 114,210,934 (Indirect Direct) | View |
| 2022-11-22 Purchase | 2022-11-25 09:00 am | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 70,000 | $0.08 | $5,600 | 114,090,934 (Indirect Direct) | View |
| 2022-09-26 Purchase | 2022-09-28 09:15 am | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 20,000 | $0.068 | $1,360 | 114,020,934 (Indirect Direct) | View |
| 2022-08-25 Purchase | 2022-08-29 09:15 am | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 80,000 | $0.082 | $6,560 | 114,000,934 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-10 Option Award | 2026-07-23 4:00 pm | N/A N/A | Oncotelic Therapeutics Inc. | OTLC | Fein Seymour Howard CRO/CMO | 250 | $0 | 250 (Direct) | View |
| 2026-07-10 Option Award | 2026-07-21 4:00 pm | N/A N/A | Oncotelic Therapeutics Inc. | OTLC | KING STEVEN W Director | 250 | $0 | 250 (Direct) | View |
| 2026-07-10 Option Award | 2026-07-14 4:00 pm | N/A N/A | Oncotelic Therapeutics Inc. | OTLC | MAIDA ANTHONY E III DIRECTOR AND CMO - TRANS. MED. Director | 1,500 | $0 | 1,500 (Direct) | View |
| 2026-07-10 Option Award | 2026-07-14 4:00 pm | N/A N/A | Oncotelic Therapeutics Inc. | OTLC | Saund Saran CBO | 1,500 | $0 | 1,500 (Direct) | View |
| 2026-07-10 Option Award | 2026-07-14 4:00 pm | N/A N/A | Oncotelic Therapeutics Inc. | OTLC | Shah Amit B. CFO | 1,500 | $0 | 1,500 (Direct) | View |
| 2026-07-10 Option Award | 2026-07-14 4:00 pm | N/A N/A | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 2,000 | $0 | 117,779,232 (Direct) | View |
| 2026-01-22 Option Award | 2026-01-26 5:15 pm | N/A N/A | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 4,426 | $0 | 8,491 (Direct) | View |
| 2025-11-17 Option Award | 2025-11-19 3:45 pm | N/A N/A | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong CHAIRMAN AND CEO 10% Owner | 4,065 | $0 | 4,065 (Direct) | View |
| 2021-09-03 Option Award | 2021-09-08 5:00 pm | N/A 2031-09-03 | Oncotelic Therapeutics Inc. | OTLC | Trieu Vuong Chief Executive Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2021-09-03 Option Award | 2021-09-08 5:00 pm | N/A 2031-09-03 | Oncotelic Therapeutics Inc. | OTLC | MAIDA ANTHONY E III Chief Clin. Ops. Officer | 600,000 | $0 | 600,000 (Direct) | View |
| 2021-09-03 Option Award | 2021-09-08 5:00 pm | N/A 2031-09-03 | Oncotelic Therapeutics Inc. | OTLC | KING STEVEN W Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2021-09-03 Option Award | 2021-09-08 5:00 pm | N/A 2031-09-03 | Oncotelic Therapeutics Inc. | OTLC | Saund Saran Chief Business Officer | 675,000 | $0 | 675,000 (Direct) | View |